Abstract
We investigated immunohistochemical localization of P‐glycoprotein (F‐gp) on paraffin‐embedded sections from 103 cases of previously untreated pancreatic tumors and also analyzed multidrug resistance‐1 (MDR1) gene expression by polymerase chain reaction after reverse transcription in 35 cases. High positive staining for P‐gp was observed in 72.8% of pancreatic tumors and in 73.2% of ductal adenocarcinoma. In ductal adenocarcinoma, immunoreactivity of P‐gp was inversely correlated with biological aggressiveness of tumors determined by histologic grading (P<0.01), tumor size (P<0.01), retroperitoneal invasion (P<0.01) and portal invasion (P<0.05). Expression of the MDR1 gene was detected in all the pancreatic tumors examined and was significantly higher than that in normal pancreas (P<0.05). The levels of MDR1 mRNA showed a moderate correlation with those of P‐gp (r=0.62, P<0.0001). Higher expression levels of MDR1/P‐gp significantly correlated with better prognosis of patients with ductal carcinoma (P<0.05). Among patients with ductal carcinoma, the high staining group for P‐gp revealed a 3.5‐fold better prognosis compared with the low staining group (HR=3.47, 95% CI=1.62, 7.45; P=0.0016). In conclusion, MDR1 gene/P‐gp expression in pancreatic cancer without chemotherapy inversely correlates with biological aggressiveness and is an independent indicator of favorable prognosis.
Keywords: P‐Glycoprotein, MDR1 gene, Expression, Prognosis, Pancreatic cancer
Full Text
The Full Text of this article is available as a PDF (730.3 KB).
REFERENCES
- 1. ) Poston , J. G. , Gilespie , J. and Guillou , P. J.Biology of pancreatic cancer . Gut , 32 , 800 – 812 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Wils , J. A.Current status of chemotherapy in metastatic pancreatic cancer . Anticancer Res. , 9 , 1027 – 1032 ( 1989. ). [PubMed] [Google Scholar]
- 3. ) Arbuck , S. G.Overview of chemotherapy for pancreatic cancer . Int. J. Pancreat. , 7 , 209 – 222 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Gottesman , M. M. and Pastan , I.Biochemistry of multidrug resistance mediated by the multidrug transporter . Annu. Rev. Biochem. , 62 , 385 – 427 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Ueda , K. , Cornwell , M. M. , Gottesman , M. M. , Pastan , I. , Roninson , I. B. , Ling , V. and Riordan , J. R.The MDR1 gene, responsible for multidrug‐resistance, codes for P‐glycoprotein . Biochem. Biophys. Res. Commun. , 141 , 956 – 962 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Chan , H. S. L. , Thorner , P. S. , Haddad , G. and Ling , V.Immunohistochemical detection of P‐glycoprotein: prognostic correlation in soft tissue sarcoma of childhood . J. Clin. Oncol. , 8 , 689 – 704 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Chan , H. S. L. , Haddad , G. , Thorner , P. S. , DeBoer , G. , Lin , Y. P. , Ondrusek , N. , Yeger , H. and Ling , V.P‐glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma . N. Engl. J. Med. , 325 , 1608 – 1614 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Verelle , P. , Meissonnier , F. , Fonck , Y. , Feillel , V. , Dionet , C. , Kwiatkowski , F. , Plagne , R. and Chassagne , J.Clinical relevance of immunohistochemical detection of multidrug resistance P‐glycoprotein in breast carcinoma . J. Natl. Cancer Inst. , 83 , 111 – 116 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Pirker , R. , Wallner , J. , Geissler , K. , Linkesch , W. , Haas , O. A. , Bettelheim , P. , Hopfner , M. , Scherrer , R. , Valent , P. , Havelec , L. , Ludwig , H. and Lechner , K.MDR1 gene expression and treatment outcome in acute myeloid leukemia . J. Natl. Cancer Inst. , 83 , 708 – 712 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Goldstein , L. J. , Galski , H. , Fojo , A. , Willingham , M. , Lai , S. L. , Gazdar , A. , Pirker , R. , Green , A. , Crist , W. , Brodeur , G. M. , Lieber , M. , Cossman , J. , Gottesmann , M. M. and Pastan , I.Expression of a multidrug resistance gene in human cancers . J. Natl Cancer Inst. , 81 , 116 – 124 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Cordon‐Cardo , C. , O'Brien , J. P. , Boccia , J. , Casals , D. , Bertino , J. R. and Melamed , M. R.Expression of the multidrug resistance gene product (P‐glycoprotein) in human normal and tumor tissues . J. Histochem. Cytochem. , 38 , 1277 – 1287 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Sugawara , I. , Kataoka , I. , Morishita , Y. , Hamada , H. , Tsuruo , T. , Itoyama , S. and Mori , S.Tissue distribution of P‐glycoprotein encoded by a multidrug‐resistance gene as revealed by a monoclonal antibody, MRK16 . Cancer Res. , 48 , 1926 – 1929 ( 1988. ). [PubMed] [Google Scholar]
- 13. ) Japan Pancreas Society . “ General Rules for Cancer of the Pancreas ,” 3rd Ed. ( 1993. ). Kanehara Co. , Tokyo ( in Japanese ). [Google Scholar]
- 14. ) Zerbi , A. , Balzano , G. , Bottura , R. and Di Carlo , V.Reliability of pancreatic cancer staging classification . Int. J. Pancreatol. , 15 , 13 – 18 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Arao , S. , Suwa , H. , Mandai , M. , Tashiro , H. , Miyazaki , K. , Okamura , H. , Nomura , H. , Hiai , H. and Fukumoto , M.Expression of multidrug resistance gene and localization of P‐glycoprotein in human primary ovarian cancer . Cancer Res. , 54 , 1355 – 1359 ( 1994. ). [PubMed] [Google Scholar]
- 16. ) Charpin , C. , Vielh , P. , Duffaud , F. , Devictor , B. , Andrac , L. , Lavaut , M. N. , Allasia , C. , Horshowski , N. and Piana , L.Quantitative immunocytochemical assays of P‐glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators . J. Natl Cancer Inst. , 20 , 1539 – 1545 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Fojo , A. T. , Ueda , K. , Slamon , D. J. , Poplack , D. G. , Gottesman , M. M. and Pastan , I.Expression of a multidrug‐resistance gene in human tumors and tissues . Proc. Natl. Acad. Sci. USA , 84 , 265 – 269 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. ) van der Valk , P. , van Kalken , C. K. , Ketelaars , H. , Broxterman , H. J. , Scheffer , G. , Kuiper , C. M. , Tsuruo , T. , Lankelma , J. , Meijer , C. J. L. M. , Pinedo , H. M. and Scheper , R. J.Distribution of multi‐drug resistance‐associated P‐glycoprotein in normal and neoplastic human tissues . Ann. Oncol. , 1 , 56 – 64 ( 1990. ). [PubMed] [Google Scholar]
- 19. ) Thiebaut , F. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. , Pastan , I. and Willingham , M. C.Cellular localization of the multidrug‐resistance gene product P‐glycoprotein in normal human tissues . Proc. Natl. Acad. Sci. USA , 84 , 7735 – 7738 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. ) Pileri , S. A. , Sabattini , E. , Tazzaari , P. L. , Gherlinzoni , F. , Michieli , M. G. , Damiani , D. , Zucchini , L. , Gobbis , M. , Tsuruo , T. and Baccarani , M.Immunohistochemical detection of the multidrug transport protein p170 in human normal tissues and malignant lymphomas . Histopathology , 19 , 131 – 140 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Thevenod , F. , Anderie , I. and Schulz , I.Monoclonal antibodies against MDR1 P‐glycoprotein inhibit chloride conductance and label a 65‐kDa protein in pancreatic zymogen granule membranes . J. Histochem. Cytochem. , 269 , 24410 – 24417 ( 1994. ). [PubMed] [Google Scholar]
- 22. ) Broxterman , H. J. , Pinedo , H. M. , Kuiper , C. M. , van der Hoeven , J. J. M. , Lange , P. , Quak , J. J. , Scheper , R. J. , Keizer , H. G. , Schuurhuis , G. J. and Lankelma , J.Immunohistochemical detection of P‐glycoprotein in human tumor cells with a low degree of drug resistance . Int. J. Cancer , 43 , 340 – 343 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 23. ) Wallner , J. , Depisch , D. , Gsur , A. , Gotzl , M. , Haider , K. , Pirker , R.MDR1 gene expression and its clinical relevance in primary gastric carcinoma . Cancer , 71 , 667 – 671 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 24. ) Raman , P. and Dewchand , H.Expression of mdr1/p‐glycoprotein and p110 in neuroblastoma . J. Pathol. , 175 , 13 – 22 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 25. ) Nakagawa , A. , Kadomatsu , K. , Sato , S. , Kohno , K. , Takano , H. , Akazawa , K. , Nose , Y. and Kuwano , M.Inverse correlation between expression of multidrug resistance gene and N‐myc oncogene in human neuroblastomas . Cancer Res. , 50 , 3043 – 3047 ( 1990. ). [PubMed] [Google Scholar]
- 26. ) Sinicrope , F. A. , Hart , J. , Brasitus , T. A. , Michelassi , F. , Lee , J. and Safa , A. R.Relationship of P‐glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse . Cancer , 74 , 2908 – 2918 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 27. ) Bradley , G. , Sharma , R. , Rajalakshmi , S. and Ling , V.P‐Glycoprotein expression during tumor progression in the rat liver . Cancer Res. , 52 , 5154 – 5161 ( 1992. ). [PubMed] [Google Scholar]
- 28. ) Kanamaru , H. , Kakehi , Y. , Yoshida , O. , Nakanishi , S. , Pastan , I. and Gottesman , M. M.MDR1 levels in human renal cell carcinomas: correlation with grade and prediction of doxorubicin resistance by quinidine in tumor explants . J. Natl. Cancer Inst. , 81 , 844 – 849 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 29. ) Bani , D. , Brandi , M. L. , Axiotis , C. A. and Bani‐Sacchi , T.Detection of P‐glycoprotein on endothelial and endocrine cells of the human pancreatic islets by C 494 monoclonal antibody . Histochemistry , 98 , 207 – 209 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 30. ) Holzmayer , T. A. , Hilsenbeck , S. , von Hoff , D. D. and Roninson , I. B.Clinical correlations of MDR1 (P‐glycoprotein) gene expression in ovarian and small‐cell lung carcinomas . J. Natl Cancer Inst. , 84 , 1486 – 1491 ( 1992. ). [DOI] [PubMed] [Google Scholar]